ERIC A. ADAMS - 02 Jun 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
President & CEO, Director
Signature
/s/ Brenda Edwards, attorney-in-fact for Mr. Eric A Adams
Issuer symbol
INM
Transactions as of
02 Jun 2022
Net transactions value
$0
Form type
4
Filing time
02 Jun 2022, 14:50:27 UTC
Previous filing
18 Apr 2022
Next filing
18 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -13,636 -3.9% $0.000000 337,576 02 Jun 2022 Common shares 13,636 $11.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00